SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge💹Economics📊Experiments🤖Agents🚦Status📑Docs
Showcase
⭐Showcase📽DemoℹVision
📖

DTI White Matter Changes in CBS/PSP

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-biomarkers-dti-white-matter-cbs-psp
Related Entities
biomarkers-dti-white-matter-cbs-psp
Metadata
slugbiomarkers-dti-white-matter-cbs-psp
entity_typebiomarker
kg_node_idNone
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (134)
mentions🧪Netrin-1 Gradient Restoration100%
mentions🧪Complement C1q Subtype Switching100%
mentions🧪Microglial Purinergic Reprogramming100%
mentions🧪Sphingolipid Metabolism Reprogramming100%
mentions🧪Glial Glycocalyx Remodeling Therapy100%
mentions🧪Aquaporin-4 Polarization Rescue100%
mentions🧪Ephrin-B2/EphB4 Axis Manipulation100%
mentions🧫Computational Modeling of Alpha-Synuclein Propagation in PD70%
mentions🧫ALS Progression Rate Heterogeneity — mechanism and biomarker70%
mentions🧫ALS Regional Onset and Spread: Network-Level Staging Model70%
mentions🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti70%
mentions🧫Axonal Transport Dysfunction Validation in Parkinson's 70%
mentions🧫Cognitive Reserve Mechanisms in Alzheimer's Disease — M70%
mentions🧫Cholinergic System Dysfunction in DLB — Mechanisms and Thera70%
mentions🧫Down Syndrome Alzheimer's Disease: Mechanisms and Thera70%
mentions🧫Endocannabinoid System Dysfunction Validation in Parkinson&#70%
mentions🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation70%
mentions🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&70%
mentions🧫Microglial Contributions to Huntington's Disease Pathog70%
mentions🧫N-of-1 Clinical Trial Design for CBS/PSP70%
mentions🧫Neural Stem Cell Therapy for Alzheimer's Disease70%
mentions🧫Non-Motor Symptom Progression in Parkinson's Disease — 70%
mentions🧫NPH Glymphatic System Interaction Experiment70%
mentions🧫Peroxisome Dysfunction Validation in Parkinson's Diseas70%
mentions🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers70%
mentions🧫Pre-Symptomatic Detection and Intervention Timing in Genetic70%
mentions🧫Progranulin Replacement Therapy for FTD — Vector Development70%
mentions🧫Spinocerebellar Ataxia (SCA) Disease-Modifying Therapy Devel70%
mentions🧫Senolytic Therapy (D+Q) Phase IIa Trial in Early Alzheimer&#70%
mentions🧫Sleep and Circadian Dysfunction as Driver of Neurodegenerati70%
mentions🧫Sleep and Respiratory Network Interaction in ALS — Experimen70%
mentions🧫Traumatic Brain Injury and Alzheimer's Disease Relation70%
mentions🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal70%
mentions🧫Vascular Contribution to Alzheimer's Disease — Beyond A70%
mentions🧫Vascular Contributions to Alzheimer Disease and Mixed Pathol70%
mentions🧫Wilson Disease Neurodegeneration: Mechanism and Therapeutic 70%
related🧫CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🧫Macroautophagy Dysfunction in PD - Experiment Design70%
related🧫4R-Tau Targeting Therapies for PSP and CBS70%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri70%
related🧫Brainstem Circuit Modulation for PSP70%
related🧫Levodopa Response Determinants in PSP — Biomarker-Guided Pre70%
related🧫PSP and CBS Biomarker Validation Study70%
related🧫Tau Pathology Initiation Zone Identification70%
related🧫Tau Spreading Network Mapping via Spatial Transcriptomics in70%
related🧫CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi70%
related🧫N-of-1 Clinical Trial Design for CBS/PSP70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🧫Macroautophagy Dysfunction in PD - Experiment Design70%
related🧫4R-Tau Targeting Therapies for PSP and CBS70%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri70%
related🧫Brainstem Circuit Modulation for PSP70%
related🧫Levodopa Response Determinants in PSP — Biomarker-Guided Pre70%
related🧫PSP and CBS Biomarker Validation Study70%
related🧫Tau Pathology Initiation Zone Identification70%
related🧫Tau Spreading Network Mapping via Spatial Transcriptomics in70%
related🧫Computational Modeling of Alpha-Synuclein Propagation in PD63%
related🧫ALS Progression Rate Heterogeneity — mechanism and biomarker63%
related🧫ALS Regional Onset and Spread: Network-Level Staging Model63%
related🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti63%
related🧫Axonal Transport Dysfunction Validation in Parkinson's 63%
related🧫Cognitive Reserve Mechanisms in Alzheimer's Disease — M63%
related🧫Cholinergic System Dysfunction in DLB — Mechanisms and Thera63%
related🧫Down Syndrome Alzheimer's Disease: Mechanisms and Thera63%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#63%
related🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation63%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&63%
related🧫Microglial Contributions to Huntington's Disease Pathog63%
related🧫N-of-1 Clinical Trial Design for CBS/PSP63%
related🧫Neural Stem Cell Therapy for Alzheimer's Disease63%
related🧫Non-Motor Symptom Progression in Parkinson's Disease — 63%
related🧫NPH Glymphatic System Interaction Experiment63%
related🧫Peroxisome Dysfunction Validation in Parkinson's Diseas63%
related🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers63%
related🧫Pre-Symptomatic Detection and Intervention Timing in Genetic63%
related🧫Progranulin Replacement Therapy for FTD — Vector Development63%
related🧫Spinocerebellar Ataxia (SCA) Disease-Modifying Therapy Devel63%
related🧫Senolytic Therapy (D+Q) Phase IIa Trial in Early Alzheimer&#63%
related🧫Sleep and Circadian Dysfunction as Driver of Neurodegenerati63%
related🧫Sleep and Respiratory Network Interaction in ALS — Experimen63%
related🧫Traumatic Brain Injury and Alzheimer's Disease Relation63%
related🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal63%
related🧫Vascular Contribution to Alzheimer's Disease — Beyond A63%
related🧫Vascular Contributions to Alzheimer Disease and Mixed Pathol63%
related🧫Wilson Disease Neurodegeneration: Mechanism and Therapeutic 63%
mentions🔬What are the mechanisms underlying 4r-tau strain-specific sp60%
mentions🔬PSP and CBD both involve 4R-tau but produce distinct neuropa60%
see_also📖Genes60%
see_also📖Aging vs Neurodegeneration: Mechanistic Comparison Matrix60%
see_also📖Frontotemporal Dementia (FTD)60%
see_also📖Apoptosis in Neurodegeneration60%
see_also📖cdkn2a60%
see_also📖DUSP10 Gene60%
see_also📖Alzheimer Indonesia60%
see_also📖Dementia Australia60%
see_also📖diseases-amyotrophic-lateral-sclerosis60%
see_also📖Packard Center for ALS Research60%
see_also📖Autophagy Enhancement Drug Screening for Neurodegeneration60%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp54%
related🔬PSP and CBD both involve 4R-tau but produce distinct neuropa54%
mentions🧫4R-Tau Targeting Therapies for PSP and CBS50%
mentions🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri50%
mentions🧫Brainstem Circuit Modulation for PSP50%
mentions🧫Levodopa Response Determinants in PSP — Biomarker-Guided Pre50%
mentions🧫PSP and CBS Biomarker Validation Study50%
mentions🧫Tau Pathology Initiation Zone Identification50%
mentions🧫Tau Spreading Network Mapping via Spatial Transcriptomics in50%
mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%
mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%
mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%
mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%
mentions🧪Competitive APOE4 Domain Stabilization Peptides50%
mentions🧪APOE Isoform Expression Across Glial Subtypes50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🧪Gut Barrier Permeability-α-Synuclein Axis Modulation50%
mentions🔬What are the mechanisms underlying digital biomarkers and ai40%
mentions🔬Investigate how lipid raft composition (cholesterol metaboli40%
mentions🔬Analyze circuit-level changes in neurodegeneration using All40%
mentions🔬What gene expression changes in the aging mouse brain predic40%
mentions🔬What gene expression changes in the aging mouse brain predic40%
mentions🔬What gene expression changes in the aging mouse brain predic40%
mentions🔬What gene expression changes in the aging mouse brain predic40%
mentions🔬What gene expression changes in the aging mouse brain predic40%
related🔬What are the mechanisms underlying apoe4 structural biology 40%
related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas40%
related🧪Oligodendrocyte White Matter Vulnerability35%

💬 Discussion

SciDEX — scidex.ai — Dashboard | Mission Control | Status | How it Works | GitHub